Results 91 to 100 of about 5,685 (219)

Extended-Infusion Eptifibatide to Prevent Stent Thrombosis in a Patient Undergoing Orthopedic Surgery

, 2011
Objective: To report the use of extended-infusion eptifibatide in a patient who had undergone placement of a drug-eluting stent and required repeat intervention of a hip fracture following mechanical failure.
Matthew J Kauflin, Bryan D Lizza
core   +1 more source

The Effects of Aprotinin on Platelet Function in Blood Exposed to Eptifibatide: An

, 2023
The preoperative use of platelet inhibitors has increased the risk of bleeding during cardiac surgery. Aprotinin has been shown to preserve hemostatic function in patients undergoing CPB.
Lynette M. Hock, Hunter B. Holcomb, Ryan G. Schmer, Bernadette T. Nutter, Rebecca L. Ahlgren, Alfred H. Stammers, Tunisia A. Ellis, Chen Gao   +7 more
core   +1 more source

Eptifibatide in Acute Coronary Syndrome

, 2014
Background: Eptifibatide is a glycoprotein IIb/IIIa inhibitor indicated for use in acute coronary syndrome (ACS), including patients who are medically managed or undergo percutaneous coronary intervention (PCI).
Stevens, Brooke, Dugdale, Erica
core  

Retrospective, Observational Comparison of Eptifibatide vs Abciximab in Patients Undergoing Percutaneous Coronary Intervention

, 2004
Purpose To provide outcome data to health care practitioners involved in the care of patients undergoing percutaneous coronary intervention (PCI). Adjunctive treatment with eptifibatide can be used in a wide range of patients requiring glycoprotein IIb ...
Joseph G. Ottinger
core   +2 more sources

Stabilization of eptifibatide by cosolvents

, 2000
Eptifibatide is a potent and highly specific inhibitor of platelet receptor glycoprotein IIb/IIIa and is indicated in the treatment of acute coronary syndrome.
Zhao, Luwei
core  

Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells

Cardiovascular Diabetology, 2008
Background The use of abciximab (c7E3 Fab) or eptifibatide improves clinical outcomes in diabetics undergoing percutaneous coronary intervention. These β3 integrin inhibitors antagonize fibrinogen binding to αIIbβ3 integrins on platelets and ligand ...
Huang Jianhua, Zhao Renyi, Pathak Alokkumar, Stouffer George A   +3 more
doaj   +1 more source

Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia. [PDF]

, 2011
A 57-year-old man with a history of coronary artery disease and placement of an implantable cardioverter-defibrillator presented at our emergency room with an anterior ST-elevation myocardial infarction.
Yang, Eric H, Burstein, Steven, Zhiroff, Katrine A, Perez, Edwin   +3 more
core  

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban

Кардиоваскулярная терапия и профилактика, 2008
The review presents literature data on the key role of platelet aggregation (PA) for intracoronary thrombogenesis in various acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI).
T. A. Batyraliev, D. V. Preobrazhensky, D. V. Fetzer, B. A. Sidorenko, S. A. Pataraya   +4 more
doaj  

Switch from abciximab to eptifibatide during percutaneous coronary intervention

, 2009
BACKGROUND: Treatment with glycoprotein (GP) IIb/IIIa inhibitors during percutaneous coronary intervention (PCI) reduce ischemic complications and improve outcome.
Grip, Lars,, Odell, Annika,, Tahmasebiepour, Farshad,, Karlsson, Thomas,, Matejka, Göran,, Albertsson, Per,, Wahlin, Magnus,, Wolmeryd, Christina,   +7 more
core  

Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin Effect on platelet function and thrombus formation

, 2004
ObjectivesThe goal of this study was to compare the antithrombotic effects of enoxaparin versus unfractionated heparin (UFH) when combined with eptifibatide in acute coronary syndrome (ACS) patients.BackgroundAn increasing number of high-risk ACS ...
Tobar, Ana, Battler, Alexander, Hasdai, David, Badimon, Juan J, Assali, Abid, Scapa, Erez, Lev, Eli I, Lahav, Judith, Kornowski, Ran   +8 more
core   +1 more source